PeptideDB

Clanfenur

CAS No.: 51213-99-1

Clanfenur belongs to a new group of substituted benzoylphenylureas. The drug shows both in vitro and in vivo antitumour
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Description Clanfenur belongs to a new group of substituted benzoylphenylureas. The drug shows both in vitro and in vivo antitumour activity.
molecular weight 335.76
Molecular formula C16H15ClFN3O2
CAS 51213-99-1
Storage Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility DMSO: 25 mg/mL (74.46 mM)
References 1. Jonkman-de Vries J D , Bj V D B , ten Bokkel-Huinink W W , et al. Pharmaceutical development of a parenteral formulation of the investigational anticancer drug clanfenur[J]. Pda J Pharm Sci Technol, 1997, 51(2):89-95.